{"id":53238,"date":"2026-09-11T11:59:23","date_gmt":"2026-09-11T11:59:23","guid":{"rendered":"https:\/\/www.vtmarkets.com\/pt-latam\/uncategorized\/premium-at-what-cost-unhs-recovery-faces-an-optum-health-test\/"},"modified":"2026-09-11T11:59:23","modified_gmt":"2026-09-11T11:59:23","slug":"premium-at-what-cost-unhs-recovery-faces-an-optum-health-test","status":"publish","type":"post","link":"https:\/\/www.vtmarkets.com\/pt-latam\/featured\/premium-at-what-cost-unhs-recovery-faces-an-optum-health-test\/","title":{"rendered":"Pr\u00eamio a que custo? A recupera\u00e7\u00e3o da UNH enfrenta um teste na Optum Health"},"content":{"rendered":"<figure class=\"wp-block-post-featured-image\"><img loading=\"lazy\" decoding=\"async\" width=\"1250\" height=\"700\" src=\"https:\/\/www.vtmarkets.com\/pt-latam\/wp-content\/uploads\/sites\/24\/2026\/09\/UHC.webp\" class=\"attachment-post-thumbnail size-post-thumbnail wp-post-image\" alt=\"\" style=\"object-fit:cover;\" srcset=\"https:\/\/www.vtmarkets.com\/pt-latam\/wp-content\/uploads\/sites\/24\/2026\/09\/UHC.webp 1250w, https:\/\/www.vtmarkets.com\/pt-latam\/wp-content\/uploads\/sites\/24\/2026\/09\/UHC-300x168.webp 300w, https:\/\/www.vtmarkets.com\/pt-latam\/wp-content\/uploads\/sites\/24\/2026\/09\/UHC-1024x573.webp 1024w, https:\/\/www.vtmarkets.com\/pt-latam\/wp-content\/uploads\/sites\/24\/2026\/09\/UHC-768x430.webp 768w, https:\/\/www.vtmarkets.com\/pt-latam\/wp-content\/uploads\/sites\/24\/2026\/09\/UHC-500x280.webp 500w, https:\/\/www.vtmarkets.com\/pt-latam\/wp-content\/uploads\/sites\/24\/2026\/09\/UHC-400x224.webp 400w, https:\/\/www.vtmarkets.com\/pt-latam\/wp-content\/uploads\/sites\/24\/2026\/09\/UHC-350x196.webp 350w, https:\/\/www.vtmarkets.com\/pt-latam\/wp-content\/uploads\/sites\/24\/2026\/09\/UHC-200x112.webp 200w\" sizes=\"auto, (max-width: 1250px) 100vw, 1250px\" \/><\/figure>\n\n<p><\/p>\n<p class=\"wp-block-paragraph\">A UnitedHealth entrou em 2026 em trajet\u00f3ria de recupera\u00e7\u00e3o. O lucro melhorou, a proje\u00e7\u00e3o (guidance, ou seja, a estimativa oficial da empresa para os pr\u00f3ximos resultados) foi elevada e os custos m\u00e9dicos come\u00e7aram a cair. Mas uma venda de participa\u00e7\u00e3o em 9 de setembro envolvendo a Optum Health desviou o foco para a pergunta central: essa recupera\u00e7\u00e3o sustenta as expectativas que o mercado j\u00e1 embutiu no pre\u00e7o da a\u00e7\u00e3o?<\/p>\n<p><\/p>\n\n\n<script type=\"module\" src=\"https:\/\/widgets.tradingview-widget.com\/w\/en\/tv-mini-chart.js\"><\/script>\n\n<tv-mini-chart symbol=\"NYSE:UNH\" time-frame=\"7D\" style=\"width: 100%; height: 300px\"><\/tv-mini-chart><br>\n\n\n<p><\/p>\n<p class=\"wp-block-paragraph\">A venda de participa\u00e7\u00e3o na problem\u00e1tica divis\u00e3o Optum Health <a href=\"https:\/\/finance.yahoo.com\/healthcare\/articles\/unitedhealth-slips-3-tpg-buys-144014218.html\" target=\"_blank\" rel=\"noopener nofollow\">derrubou as a\u00e7\u00f5es em cerca de 3%<\/a>, expondo a dist\u00e2ncia entre o que j\u00e1 melhorou e o que os investidores ainda querem ver. O neg\u00f3cio de seguros da UNH se estabilizou, mas o pre\u00e7o \u201ccaro\u201d (valuation com pr\u00eamio, isto \u00e9, a a\u00e7\u00e3o negocia acima da m\u00e9dia do setor) ainda depende de a Optum Health entregar a pr\u00f3xima etapa de crescimento.<\/p>\n<p><\/p>\n\n\n<h2 class=\"wp-block-heading\"><strong>A recupera\u00e7\u00e3o da UNH come\u00e7ou pelos custos m\u00e9dicos<\/strong><\/h2>\n\n\n<p><\/p>\n<p class=\"wp-block-paragraph\">Para seguradoras de \u201cmanaged care\u201d (planos de sa\u00fade que controlam custos por meio de rede credenciada e regras de uso), o \u00edndice de custo m\u00e9dico, chamado de MCR (medical cost ratio), mede quanto da receita de pr\u00eamios vai para pagar atendimentos e procedimentos (sinistros). Quanto menor esse \u00edndice, maior costuma ser o espa\u00e7o para lucro.<\/p>\n<p><\/p>\n\n<p><\/p>\n<p class=\"wp-block-paragraph\">Na UNH, o MCR virou o term\u00f4metro mais claro para saber se o salto de custos do p\u00f3s-pandemia estava voltando ao normal.<\/p>\n<p><\/p>\n\n<p><\/p>\n<p class=\"wp-block-paragraph\">O indicador <a href=\"https:\/\/www.businesswire.com\/news\/home\/20260716830877\/en\/UnitedHealth-Group-Reports-Second-Quarter-2026-Results\" target=\"_blank\" rel=\"noopener nofollow\">chegou a 89,4% no 2\u00ba tri de 2025<\/a>, comprimindo as margens (margem \u00e9 a fatia de lucro sobre receita) e contribuindo para <a href=\"https:\/\/www.reuters.com\/business\/healthcare-pharmaceuticals\/unitedhealth-signals-prolonged-pain-with-new-far-lower-profit-forecast-shares-2025-07-29\/\" target=\"_blank\" rel=\"noopener nofollow\">uma queda de mais de 40% desde o pico de 2024<\/a>, perto de US$ 600. O setor tamb\u00e9m sofreu com maior \u201cutiliza\u00e7\u00e3o\u201d (uso efetivo de consultas, exames e interna\u00e7\u00f5es), mas a escala da UNH ampliou o impacto.<\/p>\n<p><\/p>\n\n<p><\/p>\n<p class=\"wp-block-paragraph\">No 1\u00ba semestre de 2026, o MCR <a href=\"https:\/\/finance.yahoo.com\/markets\/stocks\/articles\/unitedhealth-stock-rises-39-6-160400759.html\" target=\"_blank\" rel=\"noopener nofollow\">melhorou para 85,3%, ante 87,1% um ano antes<\/a>. Essa melhora explica grande parte da recupera\u00e7\u00e3o das a\u00e7\u00f5es. E tamb\u00e9m explica por que a queda de setembro chamou aten\u00e7\u00e3o: o mercado agora olha al\u00e9m da normaliza\u00e7\u00e3o de custos e quer saber se os neg\u00f3cios de maior valor agregado justificam o pr\u00eamio no pre\u00e7o da a\u00e7\u00e3o.<\/p>\n<p><\/p>\n\n\n<h3 class=\"wp-block-heading\">A recupera\u00e7\u00e3o consertou o neg\u00f3cio de seguros.<\/h3>\n\n\n<p><\/p>\n<p class=\"wp-block-paragraph\">A melhora no neg\u00f3cio principal de seguros da UNH \u00e9 real.<\/p>\n<p><\/p>\n\n<p><\/p>\n<p class=\"wp-block-paragraph\">O MCR <a href=\"https:\/\/www.techtimes.com\/articles\/320782\/20260716\/unitedhealth-shatters-estimates-ai-trims-medical-costs-270-basis-points.htm\" target=\"_blank\" rel=\"noopener nofollow\">caiu 270 pontos-base no 2\u00ba tri de 2026<\/a> (ponto-base \u00e9 0,01 ponto percentual; 270 pontos-base = 2,70 p.p.), e a proje\u00e7\u00e3o de lucro por a\u00e7\u00e3o ajustado (EPS, earnings per share, lucro dividido pelo n\u00famero de a\u00e7\u00f5es; \u201cajustado\u201d exclui itens n\u00e3o recorrentes) para o ano foi elevada para US$ 19,50\u2013US$ 20,00. No meio do intervalo, isso indica crescimento de lucro de cerca de 21% em rela\u00e7\u00e3o ao ano anterior.<\/p>\n<p><\/p>\n\n<p><\/p>\n<p class=\"wp-block-paragraph\">A devolu\u00e7\u00e3o de capital ao acionista refor\u00e7a o quadro:<\/p>\n<p><\/p>\n\n\n<ul class=\"wp-block-list\">\n<li><strong>US$ 4 bilh\u00f5es<\/strong> em recompra de a\u00e7\u00f5es (buyback, quando a empresa compra as pr\u00f3prias a\u00e7\u00f5es para reduzir o n\u00famero em circula\u00e7\u00e3o e, em geral, aumentar o lucro por a\u00e7\u00e3o) at\u00e9 meados de julho de 2026, <a href=\"https:\/\/finance.yahoo.com\/healthcare\/articles\/5-billion-reason-buy-unitedhealth-180459988.html\" target=\"_blank\" rel=\"noopener nofollow\">a caminho de pelo menos US$ 5 bilh\u00f5es<\/a> no ano<\/li>\n\n\n\n<li><strong>US$ 4,1 bilh\u00f5es<\/strong> em dividendos pagos no 1\u00ba semestre de 2026<\/li>\n\n\n\n<li>Autoriza\u00e7\u00e3o de recompra dobrada, sinalizando confian\u00e7a da gest\u00e3o na gera\u00e7\u00e3o de caixa<\/li>\n<\/ul>\n\n\n<p><\/p>\n<p class=\"wp-block-paragraph\">Mas essa recupera\u00e7\u00e3o ficou concentrada no neg\u00f3cio de seguros. A pr\u00f3xima etapa da avalia\u00e7\u00e3o da UNH depende da Optum.<\/p>\n<p><\/p>\n\n\n<h2 class=\"wp-block-heading\">O valor da UNH al\u00e9m do seguro<\/h2>\n\n\n<p><\/p>\n<p class=\"wp-block-paragraph\">A Optum \u00e9 uma das principais raz\u00f5es para a UNH negociar acima das seguradoras tradicionais.<\/p>\n<p><\/p>\n\n<p><\/p>\n<p class=\"wp-block-paragraph\">A divis\u00e3o gerou US$ 65,7 bilh\u00f5es em <a href=\"https:\/\/www.sec.gov\/Archives\/edgar\/data\/731766\/000073176626000191\/uhgearnings_q22026vpower.htm\" target=\"_blank\" rel=\"noopener nofollow\">receita no 2\u00ba trimestre<\/a> e US$ 4 bilh\u00f5es de lucro operacional (lucro da opera\u00e7\u00e3o antes de itens financeiros e impostos), com apoio da for\u00e7a da OptumRx e da Optum Insight.<\/p>\n<p><\/p>\n\n<p><\/p>\n<p class=\"wp-block-paragraph\">Esses neg\u00f3cios d\u00e3o \u00e0 UNH exposi\u00e7\u00e3o al\u00e9m do seguro, com servi\u00e7os de farm\u00e1cia (PBM, pharmacy benefit manager \u2014 gestor de benef\u00edcios farmac\u00eauticos, que negocia pre\u00e7os e administra a compra de medicamentos), dados de sa\u00fade e infraestrutura de tecnologia. Essa plataforma mais ampla \u00e9 o motivo de o mercado avaliar a UnitedHealth de forma diferente das empresas tradicionais de managed care.<\/p>\n<p><\/p>\n\n<p><\/p>\n<p class=\"wp-block-paragraph\">O problema \u00e9 que nem todas as \u00e1reas da Optum est\u00e3o se recuperando no mesmo ritmo.<\/p>\n<p><\/p>\n\n\n<h3 class=\"wp-block-heading\">A Optum Health segue como a pe\u00e7a que falta<\/h3>\n\n\n<p><\/p>\n<p class=\"wp-block-paragraph\">A press\u00e3o est\u00e1 concentrada no neg\u00f3cio de presta\u00e7\u00e3o de servi\u00e7os (care delivery, opera\u00e7\u00e3o de cl\u00ednicas e atendimento) da Optum Health.<\/p>\n<p><\/p>\n\n<p><\/p>\n<p class=\"wp-block-paragraph\">A UnitedHealth j\u00e1 havia <a href=\"https:\/\/www.forbes.com\/sites\/brucejapsen\/2026\/01\/27\/for-unitedhealths-optum-its-back-to-basics-with-smaller-footprint\/\" target=\"_blank\" rel=\"noopener nofollow\">sinalizado em janeiro de 2026<\/a> que a Optum Health passava por uma reestrutura\u00e7\u00e3o planejada \u2014 reduzindo atua\u00e7\u00e3o em mercados com pior desempenho e encerrando contratos com prestadores que n\u00e3o combinavam com seu modelo de \u201cvalue-based care\u201d (cuidado baseado em valor, em que pagamento e incentivos dependem mais de resultados e qualidade do atendimento do que do volume de procedimentos). A <a href=\"https:\/\/www.bloomberg.com\/news\/articles\/2026-09-09\/unitedhealth-sells-interest-in-florida-wellmed-clinics-to-tpg\" target=\"_blank\" rel=\"noopener nofollow\">parceria com a TPG em setembro<\/a> vai na mesma dire\u00e7\u00e3o: em vez de operar todas as redes de cl\u00ednicas internamente, a UNH traz parceiros focados por regi\u00e3o e mant\u00e9m participa\u00e7\u00e3o (equity, fatia societ\u00e1ria) no neg\u00f3cio.<\/p>\n<p><\/p>\n\n\n<figure class=\"wp-block-embed is-type-rich is-provider-x wp-block-embed-x\"><div class=\"wp-block-embed__wrapper\">\n<blockquote class=\"twitter-tweet\" data-width=\"500\" data-dnt=\"true\"><p lang=\"en\" dir=\"ltr\"><a href=\"https:\/\/x.com\/search?q=%24UNH&amp;src=ctag&amp;ref_src=twsrc%5Etfw\">$UNH<\/a> UnitedHealth has sold an interest in some of its Florida WellMed\/Optum Health clinics to private-equity firm TPG, as it works to recover from last year\u2019s profit collapse.<br><br>CFO Wayne DeVeydt said the deal isn\u2019t about raising cash, but bringing in a local partner that can help\u2026 <a href=\"https:\/\/t.co\/sjiU48PYgV\">pic.twitter.com\/sjiU48PYgV<\/a><\/p>&mdash; Sam Badawi (@Sam_Badawi) <a href=\"https:\/\/x.com\/Sam_Badawi\/status\/2097514305042419833?ref_src=twsrc%5Etfw\">September 9, 2026<\/a><\/blockquote><script async src=\"https:\/\/platform.x.com\/widgets.js\" charset=\"utf-8\"><\/script>\n<\/div><\/figure>\n\n\n<p><\/p>\n<p class=\"wp-block-paragraph\">O CFO (diretor financeiro) Wayne DeVeydt descreveu o acordo como uma parceria local, e n\u00e3o uma capta\u00e7\u00e3o de capital, para dar foco operacional a um segmento que precisa disso \u2014 alinhado ao que o CEO da Optum, Dr. Patrick Conway, vinha dizendo: a divis\u00e3o vai concentrar esfor\u00e7os onde existe infraestrutura complementar para de fato executar bem.<\/p>\n<p><\/p>\n\n<p><\/p>\n<p class=\"wp-block-paragraph\">O movimento pode ser lido de duas formas: uma aloca\u00e7\u00e3o disciplinada de capital (decis\u00e3o de onde investir recursos) para acelerar a melhora de um segmento fraco, ou um sinal de que a Optum Health precisa de mais apoio do que o mercado esperava.<\/p>\n<p><\/p>\n\n<p><\/p>\n<p class=\"wp-block-paragraph\">Em qualquer leitura, a conclus\u00e3o \u00e9 a mesma: a Optum Health virou o ponto central para a UNH justificar seu pr\u00eamio.<\/p>\n<p><\/p>\n\n\n<h2 class=\"wp-block-heading\"><strong>O que o \u201cpr\u00eamio\u201d de valuation da UNH exige<\/strong><\/h2>\n\n\n<p><\/p>\n<p class=\"wp-block-paragraph\">A UNH negocia com pr\u00eamio relevante sobre a m\u00e9dia do setor. Esse pr\u00eamio n\u00e3o vem s\u00f3 do seguro. O investidor paga por uma empresa que combina escala em sa\u00fade com servi\u00e7os de farm\u00e1cia, capacidade de dados e uma plataforma mais ampla de servi\u00e7os via Optum.<\/p>\n<p><\/p>\n\n<p><\/p>\n<p class=\"wp-block-paragraph\">O desafio \u00e9 que um m\u00faltiplo alto deixa pouco espa\u00e7o para atrasos. O mercado n\u00e3o avalia apenas se a UNH consegue normalizar custos m\u00e9dicos. Avalia se os neg\u00f3cios que sustentam esse pr\u00eamio v\u00e3o entregar lucratividade maior.<\/p>\n<p><\/p>\n\n<p><\/p>\n<p class=\"wp-block-paragraph\">Tr\u00eas fatores devem decidir se esse pr\u00eamio segue fazendo sentido:<\/p>\n<p><\/p>\n\n\n<ul class=\"wp-block-list\">\n<li><strong>Recupera\u00e7\u00e3o de margem na Optum Health<\/strong> A margem operacional (lucro operacional dividido pela receita) da Optum Health est\u00e1 perto de 2%, abaixo do que o mercado espera de uma plataforma de sa\u00fade que sustenta m\u00faltiplo com pr\u00eamio. Sem melhora, o valuation fica dependente de promessas futuras.<br><\/li>\n\n\n\n<li><strong>Execu\u00e7\u00e3o das metas de crescimento<\/strong> O seguro j\u00e1 mostrou estabiliza\u00e7\u00e3o, mas a pr\u00f3xima fase depende de a Optum transformar escala e infraestrutura em mais contribui\u00e7\u00e3o de lucro. Qualquer atraso pode piorar a confian\u00e7a do mercado.<br><\/li>\n\n\n\n<li><strong>Sensibilidade a custos e mudan\u00e7as regulat\u00f3rias<\/strong> Maior utiliza\u00e7\u00e3o, mudan\u00e7as em reembolsos (quanto governo e planos pagam a prestadores) ou problemas nas linhas da Optum podem reduzir a previsibilidade do lucro e levar o mercado a reavaliar quanto pr\u00eamio a UNH merece.<\/li>\n<\/ul>\n\n\n\n<h2 class=\"wp-block-heading\">Por que a UNH negocia acima das pares<\/h2>\n\n\n<p><\/p>\n<p class=\"wp-block-paragraph\">A diferen\u00e7a de valuation fica mais clara ao comparar com outras grandes empresas de managed care. Cigna e CVS tamb\u00e9m lidam com seus desafios, mas t\u00eam perfil de lucro e riscos diferentes dos da UnitedHealthcare.<\/p>\n<p><\/p>\n\n\n<figure class=\"wp-block-table\"><table><tbody><tr><td class=\"has-text-align-center\" data-align=\"center\">Empresa<\/td><td class=\"has-text-align-center\" data-align=\"center\">P\/L futuro (Forward P\/E, pre\u00e7o\/lucro com base na proje\u00e7\u00e3o de lucro)<\/td><td class=\"has-text-align-center\" data-align=\"center\">Est\u00e1gio de recupera\u00e7\u00e3o<\/td><td class=\"has-text-align-center\" data-align=\"center\">Principal fator do valuation<\/td><\/tr><tr><td>UnitedHealth (UNH)<\/td><td><a href=\"https:\/\/www.gurufocus.com\/term\/forward-pe-ratio\/UNH\" target=\"_blank\" rel=\"noopener nofollow\">~17,6x<\/a><\/td><td>MCR melhorando; recupera\u00e7\u00e3o da Optum Health em andamento<\/td><td>Recupera\u00e7\u00e3o de margens da Optum<\/td><\/tr><tr><td>Cigna (CI)<\/td><td><a href=\"https:\/\/www.gurufocus.com\/term\/forward-pe-ratio\/CI\" target=\"_blank\" rel=\"noopener nofollow\">~8,5x<\/a><\/td><td>Menor exposi\u00e7\u00e3o ao Medicare ap\u00f3s sair do neg\u00f3cio<\/td><td>Press\u00e3o no PBM e transi\u00e7\u00e3o da Evernorth<\/td><\/tr><tr><td>CVS Health (CVS)<\/td><td><a href=\"https:\/\/www.gurufocus.com\/term\/forward-pe-ratio\/CVS\" target=\"_blank\" rel=\"noopener nofollow\">~13x<\/a><\/td><td>Recupera\u00e7\u00e3o ainda em curso ap\u00f3s custos m\u00e9dicos elevados<\/td><td>Custos no Medicare e disputas judiciais<\/td><\/tr><\/tbody><\/table><\/figure>\n\n\n\n<blockquote class=\"wp-block-quote is-layout-flow wp-block-quote-is-layout-flow\"><\/p>\n<p class=\"wp-block-paragraph\"><em>N\u00fameros obtidos no GuruFocus<\/em><\/p>\n<p><\/blockquote>\n\n\n<p><\/p>\n<p class=\"wp-block-paragraph\">A Cigna hoje est\u00e1 mais protegida. A sa\u00edda do Medicare Advantage (plano privado dentro do Medicare, programa p\u00fablico para idosos nos EUA) reduziu a exposi\u00e7\u00e3o a uma das maiores press\u00f5es de custo do setor, enquanto a Evernorth virou uma fonte maior de lucro.<\/p>\n<p><\/p>\n\n<p><\/p>\n<p class=\"wp-block-paragraph\">A CVS negocia com valuation menor, mas o caminho de recupera\u00e7\u00e3o parece mais longo por custos no Medicare Advantage, press\u00e3o de reembolso e disputas judiciais antigas.<\/p>\n<p><\/p>\n\n<p><\/p>\n<p class=\"wp-block-paragraph\">A UNH fica no meio: tem mais infraestrutura e mais oportunidades de melhora, mas o mercado tamb\u00e9m exige mais comprova\u00e7\u00e3o dos neg\u00f3cios que sustentam seu pr\u00eamio.<\/p>\n<p><\/p>\n\n\n<h2 class=\"wp-block-heading\">Como traders podem operar UNH<\/h2>\n\n\n<p><\/p>\n<p class=\"wp-block-paragraph\">O valuation da UNH aumenta a sensibilidade da a\u00e7\u00e3o a resultados, coment\u00e1rios sobre margens e novidades regulat\u00f3rias.<\/p>\n<p><\/p>\n\n<p><\/p>\n<p class=\"wp-block-paragraph\">A queda de 9 de setembro mostrou que os investidores reagem n\u00e3o s\u00f3 aos n\u00fameros atuais, mas tamb\u00e9m \u00e0 confian\u00e7a no prazo da recupera\u00e7\u00e3o. Uma empresa pode continuar mostrando melhora nos fundamentos (resultado e opera\u00e7\u00e3o) e, ainda assim, a a\u00e7\u00e3o ficar vulner\u00e1vel se as expectativas avan\u00e7arem mais r\u00e1pido do que a execu\u00e7\u00e3o.<\/p>\n<p><\/p>\n\n<p><\/p>\n<p class=\"wp-block-paragraph\">O consenso de analistas segue positivo, com pre\u00e7o-alvo m\u00e9dio em 12 meses de US$ 475, alta potencial de cerca de 21% ante n\u00edveis pr\u00f3ximos de US$ 391. No cen\u00e1rio pessimista (bear case, vis\u00e3o negativa), o alvo \u00e9 US$ 313, queda de aproximadamente 20%. Esse intervalo grande reflete incerteza sobre a velocidade com que a UNH consegue concluir a recupera\u00e7\u00e3o.<\/p>\n<p><\/p>\n\n\n<hr class=\"wp-block-separator has-alpha-channel-opacity\"\/>\n\n\n<p><\/p>\n<p class=\"wp-block-paragraph\">A UNH j\u00e1 reverteu boa parte do impacto da alta de custos m\u00e9dicos. O pr\u00f3ximo motor de valoriza\u00e7\u00e3o deve vir da Optum Health: se ela conseguir transformar sua posi\u00e7\u00e3o estrat\u00e9gica em margens maiores. At\u00e9 l\u00e1, a a\u00e7\u00e3o tende a continuar sens\u00edvel a resultados, tend\u00eancia de custos de sa\u00fade e qualquer sinal de mudan\u00e7a no cronograma de recupera\u00e7\u00e3o.<\/p>\n<p><\/p>\n\n<p><\/p>\n<p class=\"wp-block-paragraph\">Traders que queiram se posicionar nessa dire\u00e7\u00e3o podem usar CFDs (contratos por diferen\u00e7a: um derivativo em que se ganha ou perde pela varia\u00e7\u00e3o do pre\u00e7o, sem comprar a a\u00e7\u00e3o) para operar movimentos de curto prazo sem ter o papel. Uma vis\u00e3o positiva (bullish, de alta) depende de MCR melhorando e margens mais fortes na Optum Health. Uma vis\u00e3o negativa (bearish, de queda) foca no risco de valuation alto, press\u00e3o de custos ou atraso na recupera\u00e7\u00e3o da Optum.<\/p>\n<p><\/p>\n\n<p><\/p>\n<p class=\"wp-block-paragraph\"><strong>A VT Markets oferece United Healthcare (UNH), CVS Healthcorp (CVS) e Cigna (CI) como <a href=\"https:\/\/www.vtmarkets.com\/cfd-shares\/?utm_source=Opinion&amp;utm_content=UNH\" target=\"_blank\" rel=\"noopener\">a\u00e7\u00f5es via CFD<\/a> para negocia\u00e7\u00e3o.<\/strong><\/p>\n<p><\/p>\n\n\n<details class=\"wp-block-details is-layout-flow wp-block-details-is-layout-flow\"><summary><strong>TL;DR<\/strong><\/summary><\/p>\n<p class=\"wp-block-paragraph\"><br><strong>Por que as a\u00e7\u00f5es da UnitedHealth (UNH) ca\u00edram ap\u00f3s o acordo da Optum Health?<\/strong> <br>As a\u00e7\u00f5es recuaram cerca de 3% depois que a parceria com a TPG levantou d\u00favidas sobre a velocidade com que a Optum Health pode melhorar opera\u00e7\u00e3o e margens.<\/p>\n<p><\/p>\n\n<p><\/p>\n<p class=\"wp-block-paragraph\"><strong>O neg\u00f3cio de seguros da UnitedHealth se recupera em 2026?<\/strong> S<br>im. O MCR melhorou para 85,3% no 1\u00ba semestre de 2026, e a administra\u00e7\u00e3o elevou a proje\u00e7\u00e3o de EPS ajustado para o ano para US$ 19,50\u2013US$ 20,00.<\/p>\n<p><\/p>\n\n<p><\/p>\n<p class=\"wp-block-paragraph\"><strong>Por que a Optum Health \u00e9 importante para a a\u00e7\u00e3o da UNH?<\/strong> <br>A Optum ajuda a justificar o pr\u00eamio da UNH sobre seguradoras tradicionais. Margens fracas na Optum Health podem afetar a expectativa de lucro e o sentimento do mercado com a a\u00e7\u00e3o.<\/p>\n<p><\/p>\n\n<p><\/p>\n<p class=\"wp-block-paragraph\"><strong>Como a UNH se compara com Cigna e CVS Health?<\/strong> <br>A UNH negocia com m\u00faltiplo de lucro futuro mais alto, refletindo a plataforma mais ampla da Optum. Cigna e CVS negociam com m\u00faltiplos menores, mas enfrentam riscos diferentes em sa\u00fade e em PBM (gest\u00e3o de benef\u00edcios farmac\u00eauticos).<\/p>\n<p><\/p><\/details>\n\n\n\n\n<p class=\"wp-block-paragraph\"><b>Comece a negociar agora \u2014 clique <a href=\"https:\/\/www.vtmarkets.com\/pt-latam\/trade-now\/\">aqui<\/a> para criar a sua conta real da VT Markets.<\/b>\n\n<\/p>","protected":false},"excerpt":{"rendered":"<p>UnitedHealth ensaia virada em 2026: custos m\u00e9dicos caem, guidance sobe e lucro reage. Mas a venda na Optum Health derruba a a\u00e7\u00e3o e reacende o debate: o pr\u00eamio de valuation se sustenta?<\/p>\n","protected":false},"author":87,"featured_media":53237,"comment_status":"","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"_acf_changed":false,"footnotes":""},"categories":[4,5],"tags":[],"class_list":["post-53238","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-featured","category-opinion"],"acf":{"acf_article_selection_author":null},"aioseo_notices":[],"aioseo_head":"\n\t\t<!-- All in One SEO Pro 5.0.1.1 - aioseo.com -->\n\t<meta name=\"description\" content=\"UnitedHealth ensaia virada em 2026: custos m\u00e9dicos caem, guidance sobe e lucro reage. Mas a venda na Optum Health derruba a a\u00e7\u00e3o e reacende o debate: o pr\u00eamio de valuation se sustenta?\" \/>\n\t<meta name=\"robots\" content=\"max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n\t<link rel=\"canonical\" href=\"https:\/\/www.vtmarkets.com\/pt-latam\/featured\/premium-at-what-cost-unhs-recovery-faces-an-optum-health-test\/\" \/>\n\t<meta name=\"generator\" content=\"All in One SEO Pro (AIOSEO) 5.0.1.1\" \/>\n\t\t<meta property=\"og:locale\" content=\"en_US\" \/>\n\t\t<meta property=\"og:site_name\" content=\"VT Markets -\" \/>\n\t\t<meta property=\"og:type\" content=\"article\" \/>\n\t\t<meta property=\"og:title\" content=\"Pr\u00eamio a que custo? A recupera\u00e7\u00e3o da UNH enfrenta um teste na Optum Health - VT Markets\" \/>\n\t\t<meta property=\"og:description\" content=\"UnitedHealth ensaia virada em 2026: custos m\u00e9dicos caem, guidance sobe e lucro reage. Mas a venda na Optum Health derruba a a\u00e7\u00e3o e reacende o debate: o pr\u00eamio de valuation se sustenta?\" \/>\n\t\t<meta property=\"og:url\" content=\"https:\/\/www.vtmarkets.com\/pt-latam\/featured\/premium-at-what-cost-unhs-recovery-faces-an-optum-health-test\/\" \/>\n\t\t<meta property=\"article:published_time\" content=\"2026-09-11T11:59:23+00:00\" \/>\n\t\t<meta property=\"article:modified_time\" content=\"2026-09-11T11:59:23+00:00\" \/>\n\t\t<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n\t\t<meta name=\"twitter:title\" content=\"Pr\u00eamio a que custo? A recupera\u00e7\u00e3o da UNH enfrenta um teste na Optum Health - VT Markets\" \/>\n\t\t<meta name=\"twitter:description\" content=\"UnitedHealth ensaia virada em 2026: custos m\u00e9dicos caem, guidance sobe e lucro reage. Mas a venda na Optum Health derruba a a\u00e7\u00e3o e reacende o debate: o pr\u00eamio de valuation se sustenta?\" \/>\n\t\t<script type=\"application\/ld+json\" class=\"aioseo-schema\">\n\t\t\t{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"BlogPosting\",\"@id\":\"https:\\\/\\\/www.vtmarkets.com\\\/pt-latam\\\/featured\\\/premium-at-what-cost-unhs-recovery-faces-an-optum-health-test\\\/#blogposting\",\"name\":\"Pr\\u00eamio a que custo? A recupera\\u00e7\\u00e3o da UNH enfrenta um teste na Optum Health - VT Markets\",\"headline\":\"Pr\\u00eamio a que custo? A recupera\\u00e7\\u00e3o da UNH enfrenta um teste na Optum Health\",\"author\":{\"@id\":\"https:\\\/\\\/www.vtmarkets.com\\\/pt-latam\\\/author\\\/josephine\\\/#author\"},\"publisher\":{\"@id\":\"https:\\\/\\\/www.vtmarkets.com\\\/pt-latam\\\/#organization\"},\"image\":{\"@type\":\"ImageObject\",\"url\":\"https:\\\/\\\/www.vtmarkets.com\\\/pt-latam\\\/wp-content\\\/uploads\\\/sites\\\/24\\\/2026\\\/09\\\/UHC.webp\",\"width\":1250,\"height\":700},\"datePublished\":\"2026-09-11T11:59:23+00:00\",\"dateModified\":\"2026-09-11T11:59:23+00:00\",\"inLanguage\":\"en-US\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/www.vtmarkets.com\\\/pt-latam\\\/featured\\\/premium-at-what-cost-unhs-recovery-faces-an-optum-health-test\\\/#webpage\"},\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.vtmarkets.com\\\/pt-latam\\\/featured\\\/premium-at-what-cost-unhs-recovery-faces-an-optum-health-test\\\/#webpage\"},\"articleSection\":\"Featured, Opinion\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/www.vtmarkets.com\\\/pt-latam\\\/featured\\\/premium-at-what-cost-unhs-recovery-faces-an-optum-health-test\\\/#breadcrumblist\",\"itemListElement\":[{\"@type\":\"ListItem\",\"@id\":\"https:\\\/\\\/www.vtmarkets.com\\\/pt-latam#listItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\\\/\\\/www.vtmarkets.com\\\/pt-latam\",\"nextItem\":{\"@type\":\"ListItem\",\"@id\":\"https:\\\/\\\/www.vtmarkets.com\\\/pt-latam\\\/category\\\/featured\\\/#listItem\",\"name\":\"Featured\"}},{\"@type\":\"ListItem\",\"@id\":\"https:\\\/\\\/www.vtmarkets.com\\\/pt-latam\\\/category\\\/featured\\\/#listItem\",\"position\":2,\"name\":\"Featured\",\"item\":\"https:\\\/\\\/www.vtmarkets.com\\\/pt-latam\\\/category\\\/featured\\\/\",\"nextItem\":{\"@type\":\"ListItem\",\"@id\":\"https:\\\/\\\/www.vtmarkets.com\\\/pt-latam\\\/featured\\\/premium-at-what-cost-unhs-recovery-faces-an-optum-health-test\\\/#listItem\",\"name\":\"Pr\\u00eamio a que custo? A recupera\\u00e7\\u00e3o da UNH enfrenta um teste na Optum Health\"},\"previousItem\":{\"@type\":\"ListItem\",\"@id\":\"https:\\\/\\\/www.vtmarkets.com\\\/pt-latam#listItem\",\"name\":\"Home\"}},{\"@type\":\"ListItem\",\"@id\":\"https:\\\/\\\/www.vtmarkets.com\\\/pt-latam\\\/featured\\\/premium-at-what-cost-unhs-recovery-faces-an-optum-health-test\\\/#listItem\",\"position\":3,\"name\":\"Pr\\u00eamio a que custo? A recupera\\u00e7\\u00e3o da UNH enfrenta um teste na Optum Health\",\"previousItem\":{\"@type\":\"ListItem\",\"@id\":\"https:\\\/\\\/www.vtmarkets.com\\\/pt-latam\\\/category\\\/featured\\\/#listItem\",\"name\":\"Featured\"}}]},{\"@type\":\"Organization\",\"@id\":\"https:\\\/\\\/www.vtmarkets.com\\\/pt-latam\\\/#organization\",\"name\":\"VT Markets\",\"url\":\"https:\\\/\\\/www.vtmarkets.com\\\/pt-latam\\\/\"},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/www.vtmarkets.com\\\/pt-latam\\\/author\\\/josephine\\\/#author\",\"url\":\"https:\\\/\\\/www.vtmarkets.com\\\/pt-latam\\\/author\\\/josephine\\\/\",\"name\":\"josephine\",\"image\":{\"@type\":\"ImageObject\",\"@id\":\"https:\\\/\\\/www.vtmarkets.com\\\/pt-latam\\\/featured\\\/premium-at-what-cost-unhs-recovery-faces-an-optum-health-test\\\/#authorImage\",\"url\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/7809ddd0668c6cd297bde70914f1903a959aa8d1a194930855d6c5b37e53a6f0?s=96&d=mm&r=g\",\"width\":96,\"height\":96,\"caption\":\"josephine\"}},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/www.vtmarkets.com\\\/pt-latam\\\/featured\\\/premium-at-what-cost-unhs-recovery-faces-an-optum-health-test\\\/#webpage\",\"url\":\"https:\\\/\\\/www.vtmarkets.com\\\/pt-latam\\\/featured\\\/premium-at-what-cost-unhs-recovery-faces-an-optum-health-test\\\/\",\"name\":\"Pr\\u00eamio a que custo? A recupera\\u00e7\\u00e3o da UNH enfrenta um teste na Optum Health - VT Markets\",\"description\":\"UnitedHealth ensaia virada em 2026: custos m\\u00e9dicos caem, guidance sobe e lucro reage. Mas a venda na Optum Health derruba a a\\u00e7\\u00e3o e reacende o debate: o pr\\u00eamio de valuation se sustenta?\",\"inLanguage\":\"en-US\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.vtmarkets.com\\\/pt-latam\\\/#website\"},\"breadcrumb\":{\"@id\":\"https:\\\/\\\/www.vtmarkets.com\\\/pt-latam\\\/featured\\\/premium-at-what-cost-unhs-recovery-faces-an-optum-health-test\\\/#breadcrumblist\"},\"author\":{\"@id\":\"https:\\\/\\\/www.vtmarkets.com\\\/pt-latam\\\/author\\\/josephine\\\/#author\"},\"creator\":{\"@id\":\"https:\\\/\\\/www.vtmarkets.com\\\/pt-latam\\\/author\\\/josephine\\\/#author\"},\"image\":{\"@type\":\"ImageObject\",\"url\":\"https:\\\/\\\/www.vtmarkets.com\\\/pt-latam\\\/wp-content\\\/uploads\\\/sites\\\/24\\\/2026\\\/09\\\/UHC.webp\",\"@id\":\"https:\\\/\\\/www.vtmarkets.com\\\/pt-latam\\\/featured\\\/premium-at-what-cost-unhs-recovery-faces-an-optum-health-test\\\/#mainImage\",\"width\":1250,\"height\":700},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/www.vtmarkets.com\\\/pt-latam\\\/featured\\\/premium-at-what-cost-unhs-recovery-faces-an-optum-health-test\\\/#mainImage\"},\"datePublished\":\"2026-09-11T11:59:23+00:00\",\"dateModified\":\"2026-09-11T11:59:23+00:00\"},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/www.vtmarkets.com\\\/pt-latam\\\/#website\",\"url\":\"https:\\\/\\\/www.vtmarkets.com\\\/pt-latam\\\/\",\"name\":\"VT Markets\",\"inLanguage\":\"en-US\",\"publisher\":{\"@id\":\"https:\\\/\\\/www.vtmarkets.com\\\/pt-latam\\\/#organization\"}}]}\n\t\t<\/script>\n\t\t<!-- All in One SEO Pro -->\r\n\t\t<title>Pr\u00eamio a que custo? A recupera\u00e7\u00e3o da UNH enfrenta um teste na Optum Health - VT Markets<\/title>\n\n","aioseo_head_json":{"title":"Pr\u00eamio a que custo? A recupera\u00e7\u00e3o da UNH enfrenta um teste na Optum Health - VT Markets","description":"UnitedHealth ensaia virada em 2026: custos m\u00e9dicos caem, guidance sobe e lucro reage. Mas a venda na Optum Health derruba a a\u00e7\u00e3o e reacende o debate: o pr\u00eamio de valuation se sustenta?","canonical_url":"https:\/\/www.vtmarkets.com\/pt-latam\/featured\/premium-at-what-cost-unhs-recovery-faces-an-optum-health-test\/","robots":"max-snippet:-1, max-image-preview:large, max-video-preview:-1","keywords":"","webmasterTools":{"miscellaneous":""},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"BlogPosting","@id":"https:\/\/www.vtmarkets.com\/pt-latam\/featured\/premium-at-what-cost-unhs-recovery-faces-an-optum-health-test\/#blogposting","name":"Pr\u00eamio a que custo? A recupera\u00e7\u00e3o da UNH enfrenta um teste na Optum Health - VT Markets","headline":"Pr\u00eamio a que custo? A recupera\u00e7\u00e3o da UNH enfrenta um teste na Optum Health","author":{"@id":"https:\/\/www.vtmarkets.com\/pt-latam\/author\/josephine\/#author"},"publisher":{"@id":"https:\/\/www.vtmarkets.com\/pt-latam\/#organization"},"image":{"@type":"ImageObject","url":"https:\/\/www.vtmarkets.com\/pt-latam\/wp-content\/uploads\/sites\/24\/2026\/09\/UHC.webp","width":1250,"height":700},"datePublished":"2026-09-11T11:59:23+00:00","dateModified":"2026-09-11T11:59:23+00:00","inLanguage":"en-US","mainEntityOfPage":{"@id":"https:\/\/www.vtmarkets.com\/pt-latam\/featured\/premium-at-what-cost-unhs-recovery-faces-an-optum-health-test\/#webpage"},"isPartOf":{"@id":"https:\/\/www.vtmarkets.com\/pt-latam\/featured\/premium-at-what-cost-unhs-recovery-faces-an-optum-health-test\/#webpage"},"articleSection":"Featured, Opinion"},{"@type":"BreadcrumbList","@id":"https:\/\/www.vtmarkets.com\/pt-latam\/featured\/premium-at-what-cost-unhs-recovery-faces-an-optum-health-test\/#breadcrumblist","itemListElement":[{"@type":"ListItem","@id":"https:\/\/www.vtmarkets.com\/pt-latam#listItem","position":1,"name":"Home","item":"https:\/\/www.vtmarkets.com\/pt-latam","nextItem":{"@type":"ListItem","@id":"https:\/\/www.vtmarkets.com\/pt-latam\/category\/featured\/#listItem","name":"Featured"}},{"@type":"ListItem","@id":"https:\/\/www.vtmarkets.com\/pt-latam\/category\/featured\/#listItem","position":2,"name":"Featured","item":"https:\/\/www.vtmarkets.com\/pt-latam\/category\/featured\/","nextItem":{"@type":"ListItem","@id":"https:\/\/www.vtmarkets.com\/pt-latam\/featured\/premium-at-what-cost-unhs-recovery-faces-an-optum-health-test\/#listItem","name":"Pr\u00eamio a que custo? A recupera\u00e7\u00e3o da UNH enfrenta um teste na Optum Health"},"previousItem":{"@type":"ListItem","@id":"https:\/\/www.vtmarkets.com\/pt-latam#listItem","name":"Home"}},{"@type":"ListItem","@id":"https:\/\/www.vtmarkets.com\/pt-latam\/featured\/premium-at-what-cost-unhs-recovery-faces-an-optum-health-test\/#listItem","position":3,"name":"Pr\u00eamio a que custo? A recupera\u00e7\u00e3o da UNH enfrenta um teste na Optum Health","previousItem":{"@type":"ListItem","@id":"https:\/\/www.vtmarkets.com\/pt-latam\/category\/featured\/#listItem","name":"Featured"}}]},{"@type":"Organization","@id":"https:\/\/www.vtmarkets.com\/pt-latam\/#organization","name":"VT Markets","url":"https:\/\/www.vtmarkets.com\/pt-latam\/"},{"@type":"Person","@id":"https:\/\/www.vtmarkets.com\/pt-latam\/author\/josephine\/#author","url":"https:\/\/www.vtmarkets.com\/pt-latam\/author\/josephine\/","name":"josephine","image":{"@type":"ImageObject","@id":"https:\/\/www.vtmarkets.com\/pt-latam\/featured\/premium-at-what-cost-unhs-recovery-faces-an-optum-health-test\/#authorImage","url":"https:\/\/secure.gravatar.com\/avatar\/7809ddd0668c6cd297bde70914f1903a959aa8d1a194930855d6c5b37e53a6f0?s=96&d=mm&r=g","width":96,"height":96,"caption":"josephine"}},{"@type":"WebPage","@id":"https:\/\/www.vtmarkets.com\/pt-latam\/featured\/premium-at-what-cost-unhs-recovery-faces-an-optum-health-test\/#webpage","url":"https:\/\/www.vtmarkets.com\/pt-latam\/featured\/premium-at-what-cost-unhs-recovery-faces-an-optum-health-test\/","name":"Pr\u00eamio a que custo? A recupera\u00e7\u00e3o da UNH enfrenta um teste na Optum Health - VT Markets","description":"UnitedHealth ensaia virada em 2026: custos m\u00e9dicos caem, guidance sobe e lucro reage. Mas a venda na Optum Health derruba a a\u00e7\u00e3o e reacende o debate: o pr\u00eamio de valuation se sustenta?","inLanguage":"en-US","isPartOf":{"@id":"https:\/\/www.vtmarkets.com\/pt-latam\/#website"},"breadcrumb":{"@id":"https:\/\/www.vtmarkets.com\/pt-latam\/featured\/premium-at-what-cost-unhs-recovery-faces-an-optum-health-test\/#breadcrumblist"},"author":{"@id":"https:\/\/www.vtmarkets.com\/pt-latam\/author\/josephine\/#author"},"creator":{"@id":"https:\/\/www.vtmarkets.com\/pt-latam\/author\/josephine\/#author"},"image":{"@type":"ImageObject","url":"https:\/\/www.vtmarkets.com\/pt-latam\/wp-content\/uploads\/sites\/24\/2026\/09\/UHC.webp","@id":"https:\/\/www.vtmarkets.com\/pt-latam\/featured\/premium-at-what-cost-unhs-recovery-faces-an-optum-health-test\/#mainImage","width":1250,"height":700},"primaryImageOfPage":{"@id":"https:\/\/www.vtmarkets.com\/pt-latam\/featured\/premium-at-what-cost-unhs-recovery-faces-an-optum-health-test\/#mainImage"},"datePublished":"2026-09-11T11:59:23+00:00","dateModified":"2026-09-11T11:59:23+00:00"},{"@type":"WebSite","@id":"https:\/\/www.vtmarkets.com\/pt-latam\/#website","url":"https:\/\/www.vtmarkets.com\/pt-latam\/","name":"VT Markets","inLanguage":"en-US","publisher":{"@id":"https:\/\/www.vtmarkets.com\/pt-latam\/#organization"}}]},"og:locale":"en_US","og:site_name":"VT Markets -","og:type":"article","og:title":"Pr\u00eamio a que custo? A recupera\u00e7\u00e3o da UNH enfrenta um teste na Optum Health - VT Markets","og:description":"UnitedHealth ensaia virada em 2026: custos m\u00e9dicos caem, guidance sobe e lucro reage. Mas a venda na Optum Health derruba a a\u00e7\u00e3o e reacende o debate: o pr\u00eamio de valuation se sustenta?","og:url":"https:\/\/www.vtmarkets.com\/pt-latam\/featured\/premium-at-what-cost-unhs-recovery-faces-an-optum-health-test\/","article:published_time":"2026-09-11T11:59:23+00:00","article:modified_time":"2026-09-11T11:59:23+00:00","twitter:card":"summary_large_image","twitter:title":"Pr\u00eamio a que custo? A recupera\u00e7\u00e3o da UNH enfrenta um teste na Optum Health - VT Markets","twitter:description":"UnitedHealth ensaia virada em 2026: custos m\u00e9dicos caem, guidance sobe e lucro reage. Mas a venda na Optum Health derruba a a\u00e7\u00e3o e reacende o debate: o pr\u00eamio de valuation se sustenta?"},"aioseo_meta_data":{"post_id":"53238","title":null,"description":null,"keywords":null,"keyphrases":null,"primary_term":null,"canonical_url":null,"og_title":null,"og_description":null,"og_object_type":"default","og_image_type":"default","og_image_url":null,"og_image_width":null,"og_image_height":null,"og_image_custom_url":null,"og_image_custom_fields":null,"og_video":null,"og_custom_url":null,"og_article_section":null,"og_article_tags":null,"twitter_use_og":false,"twitter_card":"default","twitter_image_type":"default","twitter_image_url":null,"twitter_image_custom_url":null,"twitter_image_custom_fields":null,"twitter_title":null,"twitter_description":null,"schema":{"blockGraphs":[],"customGraphs":[],"default":{"data":{"Article":[],"Course":[],"Dataset":[],"FAQPage":[],"Movie":[],"Person":[],"Product":[],"ProductReview":[],"Car":[],"Recipe":[],"Service":[],"SoftwareApplication":[],"WebPage":[]},"graphName":"","isEnabled":true},"graphs":[]},"schema_type":"default","schema_type_options":null,"pillar_content":false,"robots_default":true,"robots_noindex":false,"robots_noarchive":false,"robots_nosnippet":false,"robots_nofollow":false,"robots_noimageindex":false,"robots_noodp":false,"robots_notranslate":false,"robots_max_snippet":null,"robots_max_videopreview":null,"robots_max_imagepreview":"large","priority":null,"frequency":null,"local_seo":null,"seo_analyzer_scan_date":null,"breadcrumb_settings":null,"limit_modified_date":false,"open_ai":null,"ai":null,"created":"2026-09-11 11:59:23","updated":"2026-09-11 11:59:35","focus_keyword":null,"additional_keywords":null,"truseo_locale":null},"aioseo_breadcrumb":"<div class=\"aioseo-breadcrumbs\"><span class=\"aioseo-breadcrumb\">\n\t<a href=\"https:\/\/www.vtmarkets.com\/pt-latam\" title=\"Home\">Home<\/a>\n<\/span><span class=\"aioseo-breadcrumb-separator\">&raquo;<\/span><span class=\"aioseo-breadcrumb\">\n\t<a href=\"https:\/\/www.vtmarkets.com\/pt-latam\/category\/featured\/\" title=\"Featured\">Featured<\/a>\n<\/span><span class=\"aioseo-breadcrumb-separator\">&raquo;<\/span><span class=\"aioseo-breadcrumb\">\n\tPr\u00eamio a que custo? A recupera\u00e7\u00e3o da UNH enfrenta um teste na Optum Health\n<\/span><\/div>","aioseo_breadcrumb_json":[{"label":"Home","link":"https:\/\/www.vtmarkets.com\/pt-latam"},{"label":"Featured","link":"https:\/\/www.vtmarkets.com\/pt-latam\/category\/featured\/"},{"label":"Pr\u00eamio a que custo? A recupera\u00e7\u00e3o da UNH enfrenta um teste na Optum Health","link":"https:\/\/www.vtmarkets.com\/pt-latam\/featured\/premium-at-what-cost-unhs-recovery-faces-an-optum-health-test\/"}],"_links":{"self":[{"href":"https:\/\/www.vtmarkets.com\/pt-latam\/wp-json\/wp\/v2\/posts\/53238","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.vtmarkets.com\/pt-latam\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.vtmarkets.com\/pt-latam\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.vtmarkets.com\/pt-latam\/wp-json\/wp\/v2\/users\/87"}],"replies":[{"embeddable":true,"href":"https:\/\/www.vtmarkets.com\/pt-latam\/wp-json\/wp\/v2\/comments?post=53238"}],"version-history":[{"count":0,"href":"https:\/\/www.vtmarkets.com\/pt-latam\/wp-json\/wp\/v2\/posts\/53238\/revisions"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/www.vtmarkets.com\/pt-latam\/wp-json\/wp\/v2\/media\/53237"}],"wp:attachment":[{"href":"https:\/\/www.vtmarkets.com\/pt-latam\/wp-json\/wp\/v2\/media?parent=53238"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.vtmarkets.com\/pt-latam\/wp-json\/wp\/v2\/categories?post=53238"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.vtmarkets.com\/pt-latam\/wp-json\/wp\/v2\/tags?post=53238"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}